E-pharmacy Market - By Product (OTC Products, Prescription Medicine), By Region, Growth Potential, Competitive Market Share & Global Forecast, 2023

Description

List of Tables

E-pharmacy Market is anticipated to showcase a positive trajectory through 2032, owing to the increasing availability of prescription drugs on online channels at discounted prices. In addition, the legalization of physician-prescribed drugs will also positively influence revenue generation. Additionally, the rising number of startups has resulted in intense competition among market leaders.

Besides, e-pharmacies have made buying drugs easy, especially for people who live far from a traditional pharmacy, disabled people, the elderly, and those who work very intensively. The shipping cost is also more affordable than traveling, saving money. Another advantage offered by e-pharmacy is timesaving. Delivery through e-pharmacies and customer privacy and confidentiality can further accelerate the market dynamics. As per a study, 96% of American adults claimed that technology has made filling prescriptions and managing medications easier for them.

Key providers in the market are engaging in strategic initiatives such as mergers and acquisitions, partnerships, R&D investments, and new product launches to gain a competitive edge in the industry. For instance, Flipkart, one of the leading Indian e-commerce giants, is in advanced talks to acquire Pharmallama, a Bengaluru-based online pharmacy startup. The acquisition has enabled Flipkart to expand its e-pharmacy offering, Flipkart Health+, across the Indian subcontinent.

Overall, the e-pharmacy industry is segmented in terms of product and region.

Based on the product, the prescription medicine segment is slated to grow considerably during the estimated timeframe. Wide and easy product availability will be a major factor contributing to segment growth. Besides, improving policies to enable the sale of prescription drugs will accelerate the segment revenue in the future.

For instance, Amazon in 2023, launched a new prescription drug program offering its subscribers with medications as per their requirement for a flat fee. The latest move is the conglomerate's bid to attract customers away from retail drug stores as tech players enter the healthcare sector.

Regionally, the Asia Pacific e-pharmacy industry was valued at over USD 19 billion in 2022. An increasing number of startups coupled with budding competition among the key players in the region would prompt market penetration across developing economies including India, China, Japan, and others. Not to mention, product benefits such as discounts and offers will boost expansion during the estimated timeframe. Furthermore, the increasing investment in developing healthcare infrastructure in various countries will positively influence regional growth.

Product Code: 3303

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 E-pharmacy industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product type trends
- 2.1.3 Regional trends

Chapter 3 E-pharmacy Industry Insights

3.1 Industry landscape, 2018 - 2032
3.2 Industry ecosystem analysis
- 3.2.1 Vendor matrix analysis
- 3.2.2 Distribution channel anaysis
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Rise in the number of internet users worldwide
  - 3.3.1.2 Increasing access to web-based and online services
  - 3.3.1.3 Lucrative offers and discounts along with easy availability of online prescription drugs
  - 3.3.1.4 Expanding geriatric population base coupled with growing prevalence of chronic disorders
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Increasing number of illegal online pharmacies
  - 3.3.2.2 Risk of counterfeit drugs
3.4 Growth potential analysis
- 3.4.1 By product type
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Current and future scenario of online pharmacies
3.8 E-pharmacy market script volume, by payer mix, 2018-2032
3.9 E-pharmacy business models
3.10 Bifurcation between OTC and Rx
3.11 Porter's analysis
3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Walmart Inc
- 4.1.2 Walgreens Boots Alliance
- 4.1.3 Optum Rx (UnitedHealth Group Incorporated)
4.2 Company market share, 2021
4.3 Competitive dashboard, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix

Chapter 5 E-pharmacy Market, By Product Type

5.1 Key segment trends
5.2 OTC products
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Prescription medicine
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 E-pharmacy Market Market, By Region

6.1 Key regional trends
6.2 North America
- 6.2.1 U.S.
- 6.2.2 Canada
6.3 Europe
- 6.3.1 Germany
- 6.3.2 UK
- 6.3.3 France
- 6.3.4 Spain
- 6.3.5 Italy
- 6.3.6 Russia
- 6.3.7 Belgium
- 6.3.8 Switzerland
- 6.3.9 Netherlands
- 6.3.10 Norway
6.4 Asia Pacific
- 6.4.1 China
- 6.4.2 Japan
- 6.4.3 India
- 6.4.4 Australia
- 6.4.5 South Korea
- 6.4.6 Indonesia
- 6.4.7 Thailand
- 6.4.8 New Zealand
- 6.4.9 Singapore
6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Mexico
- 6.5.3 Argentina
- 6.5.4 Colombia
- 6.5.5 Chile
6.6 Middle East & Africa
- 6.6.1 South Africa
- 6.6.2 Saudi Arabia
- 6.6.3 UAE
- 6.6.4 Egypt
- 6.6.5 Iran

Chapter 7 Company Profiles

7.1 Walmart Inc.
7.2 The Kroger Co.
7.3 Express Scripts Holdings (Cigna Corporation)
7.4 CVS Health
7.5 MedsEngage
7.6 Optum Rx (UnitedHealth Group Incorporated)
7.7 Giant Eagle, Inc.
7.8 Walgreens Boots Alliance
7.9 Rite Aid Corp.
7.10 Amazon, Inc.
7.11 Alto Pharmacy
7.12 Capsule Corporation